Breaking News: Daraxonrasib Approved for Pancreatic Cancer
Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets the RAS family of proteins. Catch up on...
Search fresh public links, source activity, and ready-to-use post angles for Aacr.
Fresh curated links around AACR are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets the RAS family of proteins. Catch up on...
AACR and Kids Beating Cancer have announced a new grant to support pediatric leukemia research, with a particular focus on high-risk acute myeloid leukemia subtypes at the AACR Spe...
At the recent AACR Conference on Pancreatic Cancer, Kevan M. Shokat, PhD, FAACR, received the 2026 Stephenson Global Prize for his pioneering discoveries that opened the door to th...
Around a hundred early-career clinicians and researchers from Ukraine and Poland attended last month’s AACR on Campus event in Warsaw, held in partnership with the Maria Skłodowska...
The AACR Project GENIE Data Model, recently released by the AACR GENIE consortium, is an open-access tool designed to help simplify data harmonization in precision oncology. Learn...
The year’s biggest meeting on lung cancer research featured data suggesting a new treatment standard for an aggressive tumor as well as debate about the reliability of results from...
AcademyHealth Releases Compendium of Cancer Biomarker Initiatives: A Central Repository for Cancer Biomarker Testing Resources AcademyHealth’s Scaling Cancer Biomarker Test...
The Friends of the AACR Foundation will honor Domenick Bucci, MD, as the Humanitarian Honoree and the HEADstrong Foundation as the Community Impact Award recipient at this year’s P...
This year’s Party with a Purpose, hosted by the Friends of the AACR Foundation, will honor Robert H. Vonderheide, MD, DPhil, FAACR, and Andrew Rech, MD, PhD, of the University of P...
We're pleased to announce that Yorkshire Cancer Research is the winner of the Aisling Burnand Award 2025! The set of entries was exceptionally strong in 2025, showcasing many im...
Cancer is a threat to the health of Latinos and all people. That’s why Dr. Amelie Ramirez, director of Salud America! and the Institute for Health Promotion Research at UT Health S...
At the AACR Conference on The Science of Cancer Health Disparities, Justin Xavier Moore, PhD, MPH, of the University of Kentucky, shared a study on how neighborhood disadvantage im...
Updated results from a survey first published in the AACR Cancer Disparities Report 2026 reveal the impact of federal policy changes on cancer disparities researchers. Additional h...
Carolyn Searles and her sisters all tested positive for a BRCA1 mutation and underwent double mastectomies to reduce their breast cancer risk. Still, Carolyn was diagnosed with bre...
During the third quarter of 2026, the U.S. Food and Drug Administration approved cancer treatments that expanded the options for patients with skin, genitourinary, breast, lung, ga...
During the opening plenary session of the AACR Special Conference in Cancer Research: Bridging Discovery and Clinical Impact in Pediatric Cancer, the keynote presenter, Charles Mul...
The fall issue of Cancer Today explores treatment advances for people with multiple myeloma whose cancer has returned or stopped responding to treatment, including CAR T-cell thera...
Cancer Research Catalyst has launched a new monthly series, “Unboxing Cancer News,” that highlights exciting cancer research discoveries. Read the first installment and learn about...
Salivary gland cancer is rare, and there are no standard treatments for advanced-stage disease. Recent research supports the use of HER2-targeted therapy for patients with metastat...
NASHVILLE, Tenn. — An updated version of the blood-based SimpleScreen CRC screening test improved detection of advanced precancerous lesions while maintaining high sensitivity for...
64 research findings have been accepted, including three Proffered Paper presentations and three Rapid Oral presentations, spanning more than ten areas of oncology and supportive c...
In contrast with many cancers, uterine cancer incidence and mortality are on the rise. The disease, which is a leading cause of death among gynecologic cancers in the United States...
In memory of those who lost their lives or families as a result of what happened on September 11, 2001, this edition of Cancer Research Catalyst reviews the effects of the attacks...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.